MIRA
INFORM REPORT
|
Report Date : |
27.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
CONBA GROUP CO., LTD. |
|
|
|
|
Registered Office : |
26/F, Conba Mansion, No. 288 Jiangnan Highway, Binjiang District, Hangzhou, Zhejiang Province, 310052 Pr |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
26.06.1996 |
|
|
|
|
Com. Reg. No.: |
330000000007904 |
|
|
|
|
Legal Form : |
Limited
Liabilities Company |
|
|
|
|
Line of Business : |
Manufacturing and selling pharmaceutical products, and industrial investment. |
|
|
|
|
No. of Employees : |
4,000 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
26/F, CONBA MANSION,
NO. 288 JIANGNAN highway, BINJIANG DISTRICT, HANGZHOU, ZHEJIANG province,
310052 PR CHINA
TEL: 86 (0)
571-87774374 FAX: N/A
EXECUTIVE SUMMARY
INCORPORATION DATE : june 26, 1996
REGISTRATION NO. : 330000000007904
REGISTERED LEGAL FORM : Limited liabilities
company
STAFF STRENGTH :
4,000
REGISTERED CAPITAL : CNY 300,000,000
BUSINESS LINE :
MANUFACTURING & investing
TURNOVER :
N/A
EQUITIES :
N/A
PAYMENT :
AVERAGE
MARKET CONDITION : competitive
FINANCIAL CONDITION : N/A
OPERATIONAL TREND : STEADY
GENERAL REPUTATION : well-known
EXCHANGE RATE :
CNY 6.37
= usd 1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
CNY - China Yuan Renminbi
SC was registered as a limited liabilities co. at Zhejiang Provincial
Administration for Industry & Commerce (AIC - The official body of issuing
and renewing business license).
Company Status: Limited liabilities co. This form of business in PR
China is defined as a legal person. No more than fifty shareholders
contribute its registered capital jointly. Shareholders bear limited
liability to the extent of shareholding, and the co. is liable for its
debts only to extent of its total assets. The characteristics of this form
of co. are as follows: Upon the establishment of the
co., an investment certificate is issued to the each of shareholders. The board of directors is
comprised of three to thirteen members. The minimum registered capital
for a co. is CNY 30,000. Shareholders may take their
capital contributions in cash or by means of tangible assets or intangible
assets such as industrial property and non-patented technology. Cash contributed by all
shareholders must account for at least 30% of the registered capital. Existing shareholders have
pre-exemption right to purchase shares of the co. offered for sale by the
other shareholders and to subscribe for the newly increased registered
capital of the co.
SC’s registered business scope includes selling health food;
pharmaceutical industrial investment and development, manufacturing & selling
chemical raw materials and products (excluding dangerous goods); selling metal
materials, paper and packaging materials; retailing hardware and machinery,
textiles, general merchandise; technical advisory services, storage services,
import and export business.
SC is mainly
engaged in manufacturing and selling pharmaceutical products, and industrial
investment.
Mr. Chen
Guoping is legal representative and
chairman of SC at present.
SC is known to
have approx. 4,000 employees at present.
SC
is currently operating at the above stated address, and this address houses its
operating office in Hangzhou. SC’s employee refused to release the
detailed information of the premise.
Note:
the factory address of SC is not available.
http://www.conbagroup.com/
The website belongs to Zhejiang Conba Pharmaceutical Co., Ltd. The design is
professional and the content is well organized. At present it is in Chinese
version.
No significant events or changes were found during our checks with local
AIC.
MAIN SHAREHOLDERS:
Name %
of Shareholding
Wen Yan 8.59
Li Jianzhong 8.60
Hu Jiqiang 1.25
Lanxi Kangda Investment Development Corp.
(in Chinese pinyin) 5.00
Zhejiang Bokang Medical Investment Co., Ltd. 76.56
Lanxi Kangda Investment Development Corp.
(in Chinese pinyin)
------------------------------------------------------------------------------
Registration no.: 330781000015897
Legal representative: Ying Jun
Tel: 0579-88886366
Zhejiang Bokang Medical Investment Co., Ltd.
-----------------------------------------------------
Registration no.: 330108000034728
Legal representative: Hu Jiqiang
Tel: 0571-87774850/87774853
l
Legal representative and chairman:
Mr. Chen Guoping , born in 1960 with master’s degree, he is currently
responsible for the overall management of SC.
Working Experience(s):
At present Working in SC as
legal representative and chairman.
Also working in Zhejiang Conba Pharmaceutical Co.,
Ltd. as director.
l
Directors:
Fang Yueliang
Wu Zhongshi
Hu Jiqiang
l
Supervisor:
Cai Shaoying
SC is mainly
engaged in manufacturing and selling pharmaceutical products, and industrial
investment.
SC’s products mainly include: pharmaceuticals.
Brand: CONBA
SC sources its materials 90% from domestic
market, and 10% from overseas market. SC sells 95% of its products in domestic
market, and 5% to overseas market.
The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days.
The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.
Note: SC’s management refused to release its
supplier and client details.
Subsidiary:
Zhejiang
Conba Pharmaceutical Co., Ltd.
It
is a listed company in Shanghai Stock Exchange Market with the stock code
600572.
Overall payment appraisal :
( ) Excellent (
) Good (X) Average (
) Fair ( ) Poor
( ) Not yet determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment and our debt collection record concerning SC.
Trade payment experience : SC did not provide any name of trade/service
suppliers and we have no other sources to conduct the enquiry at present.
Delinquent
payment record : None in our database.
Debt collection record :No overdue amount owed by SC was placed to us for
collection within the last 6 years.
SC’s management
declined to release its bank details.
SC’s financial
reports were not found during our checks with the local Administration for
Industry and Commerce.
SC’s management declined
to release any financial information.
SC is considered large-sized in its line with 16 years operation
history. Taking into consideration of SC’s background and operation size,
credit up to moderate amount may be considered.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.95 |
|
|
1 |
Rs.86.56 |
|
Euro |
1 |
Rs.67.95 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.